Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates Mater Today Bio
One-year consolidation with Ponatinib 15 mg in chronic myeloid leukaemia on deep molecular response with Imatinib Ann Hematol
EASIX, a new tool to predict response and refractoriness in immune-mediated thrombotic thrombocytopenic purpura Front Immunol
HCT Pre-App Program: A Telemedicine-based Prehabilitation for Allogeneic Hematopoietic Cell Transplant candidates Blood Adv
Immunosuppressive macrophages determine the effect of cellular senescence on tumor progression Sci Adv
Angiogenic factor levels across severity stages of fetal smallness with or without associated pre-eclampsia ULTRASOUND OBST GYN
CEBPA-bZIP Mutations in AML Patients Treated With Non-Intensive Therapy: A Study by the Spanish PETHEMA Registry Hematol Oncol
Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial Lancet Oncol